CO2024003519A2 - Anticuerpo anti-ang2, método de preparación del mismo y aplicación del mismo - Google Patents

Anticuerpo anti-ang2, método de preparación del mismo y aplicación del mismo

Info

Publication number
CO2024003519A2
CO2024003519A2 CONC2024/0003519A CO2024003519A CO2024003519A2 CO 2024003519 A2 CO2024003519 A2 CO 2024003519A2 CO 2024003519 A CO2024003519 A CO 2024003519A CO 2024003519 A2 CO2024003519 A2 CO 2024003519A2
Authority
CO
Colombia
Prior art keywords
application
preparation
ang2 antibody
ang2
antibody
Prior art date
Application number
CONC2024/0003519A
Other languages
English (en)
Inventor
Jian Shi
Lijuan Fang
Yongxiang Yan
Jing Zhang
Shan Hua
Pengfei Zhou
Original Assignee
Soter Biopharma Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soter Biopharma Pte Ltd filed Critical Soter Biopharma Pte Ltd
Publication of CO2024003519A2 publication Critical patent/CO2024003519A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención se refiere a un anticuerpo de dominio único de cadena pesada anti-ANG2 y a una aplicación del mismo.
CONC2024/0003519A 2021-09-10 2024-03-20 Anticuerpo anti-ang2, método de preparación del mismo y aplicación del mismo CO2024003519A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2021/117697 WO2023035226A1 (zh) 2021-09-10 2021-09-10 抗ang2抗体及其制备方法和应用

Publications (1)

Publication Number Publication Date
CO2024003519A2 true CO2024003519A2 (es) 2024-04-29

Family

ID=85507170

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2024/0003519A CO2024003519A2 (es) 2021-09-10 2024-03-20 Anticuerpo anti-ang2, método de preparación del mismo y aplicación del mismo

Country Status (6)

Country Link
KR (1) KR20240048555A (es)
AU (1) AU2021463580A1 (es)
CA (1) CA3231417A1 (es)
CO (1) CO2024003519A2 (es)
IL (1) IL311318A (es)
WO (1) WO2023035226A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9527925B2 (en) * 2011-04-01 2016-12-27 Boehringer Ingelheim International Gmbh Bispecific binding molecules binding to VEGF and ANG2
IN2014DN06904A (es) * 2012-03-30 2015-05-15 Boehringer Ingelheim Int
WO2019134710A1 (en) * 2018-01-08 2019-07-11 Nanjing Legend Biotech Co., Ltd. Multispecific antigen binding proteins and methods of use thereof
US20220185875A1 (en) * 2019-03-18 2022-06-16 Jiangsu Hengrui Medicine Co., Ltd. Bispecific antibody specifically bound to vegf and ang2
WO2021119832A1 (en) * 2019-12-20 2021-06-24 Kisoji Biotechnology Inc. Polypeptides, protein complexes and method for making same

Also Published As

Publication number Publication date
AU2021463580A1 (en) 2024-04-11
CA3231417A1 (en) 2023-03-16
KR20240048555A (ko) 2024-04-15
WO2023035226A1 (zh) 2023-03-16
IL311318A (en) 2024-05-01

Similar Documents

Publication Publication Date Title
CL2022001670A1 (es) Inhibidores de proteínas kras mutantes
CL2018001953A1 (es) Composición farmacéutica que comprende constructos de anticuerpo biespecíficos
CO2019009365A2 (es) Anticuerpos anti-lag3
CO2018005525A2 (es) Formulación farmacéutica acuosa del anticuerpo anti-pd-l1 avelumab
CU24568B1 (es) Anticuerpo inhibidor de masp-3
CL2021001466A1 (es) Sistemas activos dinámicos acromosómicos.
CO2018008427A2 (es) Conjugado de enzimas terapéuticas
BR112018075630A2 (pt) anticorpos anti-cd98 e conjugados de fármaco de anticorpo
EA202190810A1 (ru) Способы и наборы для получения цельной крови с инактивированным патогеном
EA201992278A1 (ru) Способы и композиции для снижения иммуногенности
UY37235A (es) Conjugado de anticuerpo-fármaco de un anticuerpo antiglipicano-3 y un análogo de tubulisina, preparación y usos
DOP2023000039A (es) Moléculas de unión a antígeno multi-específicas contra el vih y métodos de uso
EA201991876A1 (ru) Антитела против фактора d и их применения
CL2023001052A1 (es) Composiciones y métodos para el tratamiento de la enfermedad ocular tiroidea
AU2021298632A8 (en) Anti-CD70 antibody and application thereof
EA202191342A1 (ru) Модуляторы экспрессии irf5
CL2021003071A1 (es) Activación de explosivos en agujeros
CL2021003036S1 (es) Par de auriculares.
CO2024003519A2 (es) Anticuerpo anti-ang2, método de preparación del mismo y aplicación del mismo
CL2020003458S1 (es) Auriculares.
CL2020000586A1 (es) Moduladores de la expresión de enac.
BR112018006170B8 (pt) Método e composição para clareamento de pele usando um extrato de cultura celular de earliella scabrosa e seu uso
EA201700555A1 (ru) Композиция сополимера пропилена
CL2021001688S1 (es) Audífono.
TR202102790U5 (tr) Kupa bardak ambalaj takımı.